Respiratory and Pulmonary System Respiratory Tract Infections

Respiratory and Pulmonary System Respiratory Tract Infections
  • Report price : $ 1 495
  • Publication date : March 2009

Get this report now!

Respiratory and Pulmonary System Respiratory Tract Infections

Life Science Analytics', Respiratory and Pulmonary System Respiratory Tract Infections contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of respiratory tract infections drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

• Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
• Keep track of your competitors and partners by better understanding their product pipeline.
• Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
• Maintain a critical competitive advantage.

RELATED REPORTS

Respiratory and Pulmonary System Pulmonary Hypertension

Respiratory and Pulmonary System Pulmonary Hypertension

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Pulmonary Hypertension contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of pulmonary hypertension drugs by company and by stage as well as a summary of the latest news and devel ...

Industries : Pathology

Respiratory and Pulmonary System Pulmonary Fibrosis

Respiratory and Pulmonary System Pulmonary Fibrosis

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Pulmonary Fibrosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of pulmonary fibrosis drugs by company and by stage as well as a summary of the latest news and developments ...

Industries : Pathology

Respiratory and Pulmonary System Nasal congestion

Respiratory and Pulmonary System Nasal congestion

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Nasal congestion contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of nasal congestion drugs by company and by stage as well as a summary of the latest news and developments in t ...

Industries : Pathology

Respiratory and Pulmonary System Cystic Fibrosis

Respiratory and Pulmonary System Cystic Fibrosis

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Cystic Fibrosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of cystic fibrosis drugs by company and by stage as well as a summary of the latest news and developments in thi ...

Industries : Pathology

Respiratory and Pulmonary System Cough

Respiratory and Pulmonary System Cough

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Cough contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of cough drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the ...

Industries : Pathology

Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life

Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life

  • $ 3 800
  • March 2009

IntroductionTuberculosis is a major cause of illness and death worldwide, but despite 14.4 million prevalent cases, 9.2 million new cases and 1.7 million deaths in 2006, the small and rapidly declining burden of disease in the seven major markets has limited drug and vaccine development activities u ...

Industries : Pathology

Stakeholder Opinions: Pulmonary Arterial Hypertension  clinical community builds order from chaos

Stakeholder Opinions: Pulmonary Arterial Hypertension clinical community builds order from chaos

  • $ 3 800
  • March 2009

IntroductionDespite an explosion in the number of drugs and treatment strategies available, pulmonary arterial hypertension is still a rapidly fatal condition for a small, hard to identify patient group. A small clinical elite is currently leading the way in advancing treatment outcomes, and is cent ...

Industries : Pathology

The Asian Cardiovascular Market Outlook to 2014: Regional and therapeutic analysis, pipeline impact and growth opportunities

The Asian Cardiovascular Market Outlook to 2014: Regional and therapeutic analysis, pipeline impact and growth opportunities

  • $ 3 835
  • March 2009

The Asian cardiovascular market demonstrated robust sales, unlike the global market which has begun to slow down due to patent expiries of class leading products and strong generic competition. The emerging ten Asian markets analyzed in this report is a mixture of developed nations like South Korea, ...

Industries : Pathology

China Cardiovascular Devices Market Analysis & Forecasts to 2015

China Cardiovascular Devices Market Analysis & Forecasts to 2015

  • $ 3 500
  • April 2009

China Cardiovascular Devices Market Analysis & Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to the China cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company sha ...

Industries : Pathology

Stakeholder Opinions: Urinary Tract Infections  Growing resistance rates bring opportunities for both new and old drugs

Stakeholder Opinions: Urinary Tract Infections Growing resistance rates bring opportunities for both new and old drugs

  • $ 5 795
  • April 2009

IntroductionUrinary tract infections (UTIs) include infections of the kidneys, ureters, and bladder. Escherichia coli is the major UTI pathogen, with emerging extended-spectrum beta-lactamase (ESBL)-producing strains proving particularly difficult to treat. Bacterial resistance to the most commonly ...

Industries : Pathology

24/7 Customer Service

Contact Clare now !

Related industries

reportlinker.com © Copyright 2010. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.